These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
203 related items for PubMed ID: 12034170
1. Combined use of FTY720 and cyclosporine A prevents chronic allograft vasculopathy. Koshiba T, Van Damme B, Lu Y, Yan Y, Rutgeerts O, Overbergh L, Tanaka K, Waer M, Mathieu C, Pirenne J. Transplant Proc; 2002 May; 34(3):748-9. PubMed ID: 12034170 [No Abstract] [Full Text] [Related]
12. Novel insights into the mechanism of action of FTY720 in a transgenic model of allograft rejection: implications for therapy of chronic rejection. Habicht A, Clarkson MR, Yang J, Henderson J, Brinkmann V, Fernandes S, Jurewicz M, Yuan X, Sayegh MH. J Immunol; 2006 Jan 01; 176(1):36-42. PubMed ID: 16365393 [Abstract] [Full Text] [Related]
13. Effect of a new immunosuppressant, FTY720, on joint allografts. Watanabe H, Hamada Y, Toshima T, Nagasawa K, Sakano Y. J Reconstr Microsurg; 1999 May 01; 15(4):295-8. PubMed ID: 10363553 [Abstract] [Full Text] [Related]
14. KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts. Shimizu H, Takahashi M, Kaneko T, Murakami T, Hakamata Y, Kudou S, Kishi T, Fukuchi K, Iwanami S, Kuriyama K, Yasue T, Enosawa S, Matsumoto K, Takeyoshi I, Morishita Y, Kobayashi E. Circulation; 2005 Jan 18; 111(2):222-9. PubMed ID: 15642767 [Abstract] [Full Text] [Related]
20. Effect of a novel immunosuppressant, FTY720, on heart and liver transplantations in rats. Yamashita K, Nomura M, Omura T, Takehara M, Suzuki T, Shimamura T, Kishida A, Furukawa H, Murakami M, Uede T, Todo S. Transplant Proc; 1999 Jul 15; 31(1-2):1178-9. PubMed ID: 10083526 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]